Plasma-derived medicinal products (PDMPs) play a critical role in treating a wide range of rare and life-threatening diseases. The availability and effectiveness of these therapies are significantly influenced by the policies governing plasma collection, processing, and distribution. To deepen our understanding and facilitate impactful change, we are pleased to convene an international panel discussion focused on exploring and documenting existing plasma policies.

In today's global healthcare landscape, policymakers, healthcare professionals, and stakeholders face diverse challenges and opportunities in shaping effective plasma policies. This discussion seeks to shed light on the diverse approaches taken by countries, from those with well-established policies to those navigating the challenges of developing and implementing effective strategies.

By bringing together experts and stakeholders from various backgrounds, this panel aims to facilitate knowledge exchange, highlight best practices, and identify opportunities for collaboration and improvement in plasma policies. Through open dialogue and shared insights, we aspire to advance global efforts toward optimizing plasma-related policies for the benefit of patients worldwide.